Highlights
1 patentProfile claimed by owner
About
Vaccines for Viral and Bacterial Diseases in Fish
KoVax develops and manufactures aquaculture vaccines for viral and bacterial diseases and provides diagnostic services for all stages of fish growth. KoVax produces and markets autogenous vaccines for bacterial diseases, including the patented CyHV3 (KHV) vaccine and KV3 for koi and common carp. KV3 is a patent that KoVax acquired from the Hebrew University and the Israeli Ministry of Agriculture. The company has also developed a vaccine against TLV (TiLV).
Identity
| Name | KoVax |
|---|---|
| Slug | kovax |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6A-9wJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Acquired (Inactive) by Phibro Animal Health on Dec 2018 - closed due to acquisition |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Hartom St 19, Jerusalem, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Biologicals
Target customers
Agriculture & FoodMarine LifeFish
Business models
B2B
Tags
aquaculturepharmaceuticalsveterinarybiotechnologyagtechfish-farmslivestockdisease-managementvaccines
Funding
| Total raised | — |
|---|---|
| Current stage | Acquired |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}